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Under physiological conditions, the pentameric human plasma
protein serum amyloid P component (SAP) binds hexanoyl
bis(d-proline) (R-1-{6-[R-2-carboxy-pyrrolidin-1-yl]-6-oxo-
hexanoyl}pyrrolidine-2-carboxylic acid; CPHPC) through its
d-proline head groups in a calcium-dependent interaction.
Cooperative effects in binding lead to a substantial enhance-
ment of affinity. Five molecules of the bivalent ligand cross-
link and stabilize pairs of SAP molecules, forming a decameric
complex that is rapidly cleared from the circulation by the
liver. Here, it is reported that X-ray analysis of the SAP
complex with CPHPC and cadmium ions provides higher
resolution detail of the interaction than is observed with
calcium ions. Conformational isomers of CPHPC observed in
solution by HPLC and by X-ray analysis are compared with
the protein-bound form. These are discussed in relation to
the development of CPHPC to provide SAP depletion for the
treatment of amyloidosis and other indications.
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1. Introduction
Serum amyloid P component (SAP) is a normal plasma
glycoprotein that recognizes and binds to amyloid fibres in a
calcium-dependent fashion wherever these are deposited in
tissues (Pepys, 2006). Radiolabelled SAP is a scintigraphic
tracer that is used to image amyloid in the diagnosis and
management of amyloidosis (Hawkins & Pepys, 1995). SAP
stabilizes amyloid fibres in vitro and is likely to contribute to
their deposition and persistence in vivo, validating the inter-
action as a therapeutic target in amyloidosis (Tennent et al.,
1995). The common motif that enables recognition by SAP of
fibres produced by a range of different proteins is not known,
but the interaction with O-phosphothreonine may explain
how SAP binds to neurofibrillary tangles of tau protein
(Kolstoe et al., 2009). The first small-molecule ligand shown
to interact with SAP in a calcium-dependent reaction that
competed with fibre recognition was the pyruvate acetal of
galactose, methyl 4,6-O-(1-carboxyethylidene)--d-galacto-
pyranoside (MODG), a trace constituent of agarose and a
cell-wall component of some bacteria (Hind et al., 1984). This
ligand apparently blocks SAP binding to amyloid fibres by
occupying the pocket formed by calcium-ligating loops located
on each subunit, identifying this as the most likely amyloid-
recognition region. Two calcium ions are bound about 4 A˚
apart on each SAP subunit and are stabilized by interaction
with a range of carboxylate and amide side chains. This site is
replicated five times on one face, the binding (B) face of
the SAP pentamer, suggesting that fibre-binding affinity
may be amplified by a multi-point attachment process. The
high-affinity ligand CPHPC was later produced in a medicinal
chemistry programme following an initial high-throughput
screen for inhibitors of the binding of human SAP to amyloid
fibrils formed from the Alzheimer’s disease A1–42 peptide
(Pepys et al., 2002). Although each d-proline head group,
represented by free N-acetyl-d-proline, is weakly bound
(Kd =15 mM), the bivalent bis(d-proline) derivative is avidly
bound with a Kd of 10 nM, reflecting the multivalency gain
of avidity achieved when five ligand molecules cross-link two
pentameric SAP molecules (Pepys et al., 2002). In vivo, these
cross-linked complexes are rapidly cleared from the circula-
tion by the hepatocytes, which is a novel pharmacological
mechanism for depleting a specific plasma protein.
Structural studies of the SAP–CPHPC complex by X-ray
diffraction at medium resolution (3.2 A˚) showed that in
addition to a carboxylate interaction with the calcium site of
SAP, the pyrrolidine ring of the d-proline constituents of
CPHPC bound into a hydrophobic pocket formed by the side
chains of Tyr74, Tyr64 and Leu62. The approach of each
d-proline head group to the opposing sites of the in-register
twofold axis-related pairs of subunits of the SAP decamer
appeared to be facilitated by a kinked rotamer at the centre of
the alkyl linker (Pepys et al., 2002). This study was not able to
clearly define the geometry of the peptide bond preceding the
proline as cis or trans. Subsequent studies employing an alkyl
or a piperazine linker to couple cyclic pyruvate ketals of
glycerol as head groups allowed a substantial rotation between
opposing pentamers (more than 20) of the stabilized decamer
(Ho et al., 2005).
In this paper, we revisit the details of the structural analysis
of calcium-bound SAP in complex with CPHPC and present
a higher resolution study enabled by crystallization of the
complex with cadmium ions in order to provide guidance
for the design of a more rigid ligand. We also report a high-
resolution analysis of the interaction of N-acetyl-d-proline,
a substructure of CPHPC, with SAP in comparison with the
l-isomer. These crystallographic investigations are comple-
mented by calorimetric studies of ligand affinity and
measurements of the conformational flexibility of CPHPC in
solution, providing a number of parallels with earlier investi-
gations of the angiotensin-converting enzyme inhibitor
captopril (Nishikawa et al., 2004).
2. Materials and methods
2.1. Protein isolation
SAP was purified as described previously (Hawkins et al.,
1991; Pontet et al., 1978). Briefly, the protein was captured
from serum by calcium-dependent binding to phosphoethanol-
amine covalently immobilized on carboxyhexyl Sepharose.
C-reactive protein, which also binds to phosphoethanolamine,
was removed by elution with phosphocholine, and the SAP
was then eluted by calcium chelation with EDTA prior to gel
filtration and concentration by ultrafiltration. The protein
preparation carried forward for crystallization contained no
calcium ions.
2.2. Co-crystallizations
N-Acetyl-l-proline was obtained from Sigma–Aldrich,
N-acetyl-d-proline was obtained from Bachem AG and
CPHPC was synthesized as described previously (Pepys et al.,
2002). SAP at 11 mg ml1 was incubated with various molar
excesses of ligands at room temperature in 10 mM Tris–HCl
buffer pH 8.0, 140 mM NaCl, 5 mM CaCl2 or cadmium acetate
for approximately 2 h before being diluted with well solution
in a 1:1 ratio. Hanging-drop vapour-diffusion screens were
constructed from previously known SAP crystallization
conditions and using Molecular Dimensions Structure Screens.
2.3. Crystal structure determination of SAP–ligand
complexes
All crystals were vitrified at 100 K with 20%(v/v) glycerol
as a cryoprotectant. X-ray diffraction data were collected on
stations I03 at Diamond Light Source (DLS), Oxfordshire,
England and ID14-1 and ID14-2 at the ESRF, Grenoble,
France and were processed using MOSFLM (Leslie, 2006),
XDS and programs from the CCP4 suite (Winn et al., 2011)
or DENZO/SCALEPACK (Otwinowski & Minor, 1997).
MOLREP (Vagin & Teplyakov, 2010) or Phaser (McCoy et al.,
2007) and PDB entry 1sac (Emsley et al., 1994) were used for
molecular replacement. The structures were initially refined
with SHELXL (Sheldrick, 2008),CNS (Bru¨nger et al., 1998) or
REFMAC (Murshudov et al., 2011), but were all completed
with PHENIX (Adams et al., 2010); models were built with
Coot (Emsley & Cowtan, 2004). Validation was performed
with MolProbity (Chen et al., 2010). Completed structures
were deposited in the PDB as entries 4avs, 4ayu, 4avt and
4avv.
2.4. Crystal structure determination for CPHPC
CPHPC was crystallized in batch from cooling a
100 mg ml1 solution in aqueous acetone [80:20(v:v)] from
50C to room temperature. Data were collected by the EPSRC
small-molecule National Crystallography Service at the
University of Southampton. Intensities were recorded at
120 K using a Bruker Nonius Kappa CCD Roper area-
detector diffractometer mounted at the window of a rotating
Mo-anode (Mo K, 0.71073 A˚) generator. Unit-cell determi-
nation, data collection and processing were carried out using
DirAx (Duisenberg, 1992), Collect (Nonius) and DENZO
(Otwinowski & Minor, 1997) and a multi-scan absorption
correction was applied using SADABS (Sheldrick, 1997a). The
structure was solved by direct methods and was refined by full-
matrix least squares (Sheldrick, 1997b) on F 2 (Friedel oppo-
sites were merged). With the exception of those on the water
molecule (freely refined), all H atoms were placed in idealized
positions and were refined using a riding model. The five-
membered ring was modelled as disordered between two very
close possible conformations. Thermal parameter constraints
were applied to equivalent atoms across the two parts.
Occupancy values were initially refined and were then fixed in
the final refinement cycles.
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2.5. HPLC of CPHPC
CPHPC dissolved at 10 mg ml1 in aqueous mobile phase
was applied onto a 4.6  150 mm Gemini 3 mm C6-Phenyl
reversed-phase column (Phenomenex) equilibrated with
100 mM ammonium acetate at pH 4.5 or 7.5 and eluted at
1 ml min1 with an acetonitrile gradient using a Gilson chro-
matograph. UVabsorption was monitored at 220 nm. Samples
were cooled to 4C before application onto the column and
were eluted at this temperature in an attempt to trap the
isomer composition.
2.6. Calorimetry
Isothermal titration calorimetry was performed using a
MicroCal VP-ITC (MicroCal Inc., Northampton, Massachu-
setts, USA). Ligand was titrated into protein solution at molar
ratios of between 20:1 and 25:1, corresponding to approxi-
mately 2 mM ligand and 80 mM protein, in a buffer consisting
of 200 mM CaCl2, 10 mM Tris–HCl pH 8.0, 140 mM NaCl,
0.1%(w/v) NaN3. A high calcium chloride concentration was
used to prevent the calcium-dependent auto-aggregation of
isolated human SAP which occurs at physiological ionic
strength (Hutchinson et al., 2000). Results were averaged over
three experiments and Kd was estimated from curve-fitting
enthalpy changes using the Origin7 program.
3. Results
3.1. The SAP–CPHPC complex
structure
Crystals of the SAP–CPHPC
complex grown in the presence of
calcium ions and a tenfold molar
excess of CPHPC at 4C have
been reported previously (Pepys
et al., 2002). The crystals
contained a large tetragonal unit
cell containing approximately
83% solvent and ten SAP sub-
units in the asymmetric unit. The
crystals did not tolerate removal
from the cold room prior to
vitrification, and not unexpect-
edly their diffraction was rela-
tively weak (limited to 3.2 A˚
resolution). Radiation damage
caused rupture of some disulfide
bridges, but the conformational
effects were local. This structure
was determined using molecular
replacement, and here we have
revisited the refinement in the
light of developments in proce-
dures for medium-resolution
data. Statistics are included in
Table 1. A new crystal form of this
complex was produced from a
variant of Molecular Dimensions
Structure Screen II condition No. 38 consisting of 100 mM
cadmium chloride, 100 mM sodium acetate buffer pH 4.6,
30%(v/v) PEG 400. The monoclinic crystals had a much lower
solvent content (63%) and data were collected on BM14-1
at the ESRF to 1.6 A˚ resolution (see Table 1). A molecular-
replacement solution was found usingMOLREP with a single
SAP pentamer (PDB entry 1sac) as the search model with all
ligands and Ca atoms removed. Analysis of the resulting maps
indicated prominent difference electron density for multiple
divalent cations bound to each SAP subunit. Two were located
within the ligand-binding site of each SAP subunit, where
calcium ions are known to bind in other structures of SAP, and
three more were bound per subunit at the interface between
pentamers, ligated by Glu14 and Asp145. The strong electron
density, the mother-liquor composition and the coordination
partners suggest that these are cadmium ions. There are 35
cadmium ions in the asymmetric unit: 25 are bound at the
interface between pentamers and a further ten cadmium ions
are bound at the periphery and form lattice contacts (see
Figs. 1a, 1b and 1c). Overall, the decamer of SAP contains 50
cadmiums at the interface and 20 more at the surface. Several
of the cadmium ions are encircled by electron-density features
that we have built as acetate ions from the buffer. Approxi-
mately 1000 water molecules were added to the structure to
give a final R factor of 15.0% and a final Rfree of 17.5%. The
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Table 1
X-ray data-collection and refinement statistics for complexes of SAP with CPHPC, N-acetyl-d-proline and
N-acetyl-l-proline.
Values in parentheses are for the highest resolution shell.
N-Acetyl-l-proline N-Acetyl-d-proline
CPHPC, calcium
conditions
CPHPC, cadmium
conditions
PDB code 4avs 4ayu 4avt 4avv
Space group P21 P21 P43212 C2
Unit-cell parameters (A˚, ) a = 95.0, b = 70.0,
c = 102.4,
 = 97.0
a = 94.4, b = 70.6,
c = 99.1,
 = 96.9
a = 230.9,
b = 230.9,
c = 281.4,
 =  =  = 90
a = 154.4,
b = 108.6,
c = 120.3,
 = 138.5
Resolution range (A˚) 30.4–1.4 (1.5–1.4) 31.2–1.5 (1.6–1.5) 24.9–3.2 (3.4–3.2) 80.6–1.6 (1.7–1.6)
No. of unique reflections 251592 198644 122013 170912
Multiplicity 3.6 (3.7) 7.0 (6.9) 3.9 (3.3) 3.7 (3.5)
Completeness (%) 96.4 (95.7) 96.5 (91.0) 98.0 (95.8) 99.2 (98.4)
Rp.i.m. (%) 8.1 (26.2) 3.6 (38.5) 5.2 (38.9) 4.1 (13.2)
hI/(I)i 7.2 (3.5) 14.1 (2.6) 11.8 (2.0) 12.4 (5.0)
Wilson B factor (A˚2) 8.47 14.7 81.8 14.7
Refinement
Molecular-replacement model 1sac 1sac 1sac 1sac
No. of residues 1020 1020 2040 1020
No. of solvent molecules 1275 1362 0 1401
No. of other molecules 5 N7P, 10 Ca,
5 NAG
5 N8P, 10 Ca,
5 NAG, 5 GOL
10 GHE, 20 Ca,
10 NAG
5 GHE, 35 Cd,
8 ACT, 9 NAG,
2 MAN, 2 GAL,
3 SIA
R.m.s.d., bonds (A˚) 0.010 0.007 0.015 0.010
R.m.s.d., angles () 1.365 1.26 1.186 1.548
Ramachandran favoured (%) 98.3 98.3 95.9 97.3
Ramachandran outliers (%) 0.0 0.0 0.5 0.0
Average B factors (A˚2)
Protein 10.8 15.8 TLS used 16.6
Ligand 24.3 15.9 121.9 15.6
Solvent 27.5 31.8 — 29.8
R factor (%) 14.4 15.5 18.9 15.0
Rfree (%) 17.0 16.8 19.7 17.5
overall structure of the protein component of these complexes
is very similar to the previously reported structure.
In summary, the structure of SAP is comprised of five
identical 204-residue subunits associated in a ring 95 A˚ in
diameter and 35 A˚ deep, with radial symmetry creating a
central pore 20 A˚wide. Each protomer consists of 15 -strands
(labelled A to O from the N-terminus to the C-terminus)
arranged in two large -sheets in the form of a flattened
-barrel with jelly-roll topology. The -sheets are held nearly
perpendicular to the radial symmetry, creating two separate
and distinct faces: the A face, which contains five -helices,
and the opposing B face, which contains five double metal-
binding sites formed by the coordination of six localized
protein residues. It is at these double metal-binding sites that
CPHPC is bound. It is clear that these sites can readily
accommodate two cadmium ions without any reorganization
in spite of the substantial increase in atomic number over the
natural calcium occupants of the sites. Five molecules of the
bivalent CPHPC cross-link two SAP pentamers, which stack
on a common fivefold axis to define a decamer 95 A˚
in diameter and 75 A˚ deep (see Fig. 1e). The two proline
carboxylate groups of each CPHPC molecule bind to the
double metal-ion sites of subunits of opposing pentamers,
giving an average O—Cd distance of 2.3 A˚ (Jesu Jaya Sudan &
Sudandiradoss, 2012), with additional metal ligands provided
by the side chains of Asp58, Asn59, Gln148, Glu136, Asp138
and the carbonyl of Gln137. The d-proline side chain fits into a
pocket defined by the side chains of Tyr74, Tyr64 and Leu62
such that the pyrrolidine ring stacks against the ring of Tyr74
and forms van der Waals contacts with the other two side
chains. The electron density for the six-carbon alkyl linker
between the pyrrolidine rings shows a kinked rotamer at its
centre, facilitating the approach of each head group to the
metal site of the twofold axis-related subunit of the opposing
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Figure 1
(a) The CPHPC-bound decamer of SAP viewed normal to the fivefold axis and showing the 70 cadmium ions bound (yellow spheres). (b) Removing one
pentamer and viewing down the fivefold axis shows a pentagonal string of metal ions trapped within the decamer and peripheral sites. (c) C trace of
subunit A with eight cadmium ions, five of which (yellow spheres) form an extended line and become buried in the decamer and three of which (cyan
spheres) bind at the periphery. Portions of two adjacent subunits of the pentamer are shown as grey strands. CPHPC is shown with grey C atoms, subunit
side chains with green C atoms, acetates in cyan and waters as red spheres. (d) The tentative positioning of one partially ordered sugar chain (green
spheres) on the SAP pentamer (yellow strands, red helices). (e) Decamer of SAP with five CPHPC molecules (black) cross-linking pentamers (green
strands and red helices) between their metal sites (yellow).
SAP pentamer. Model building of the CPHPC ligand into the
tenfold NCS averaged electron density of the lower resolution
SAP–calcium map did not clearly establish whether the
peptide bond preceding the proline ring was in the cis or the
trans form, and in the deposited coordinates both cis and trans
isomers were included for each ligand. In the high-resolution
SAP–cadmium electron-density map we were able to fit two
ligands as trans isomers in subunitsA and E. In subunits B and
D density for both cis and trans isomers was present, but was
much stronger for the cis isomer (see Fig. 2). For subunit C it
appears that the cis isomer is present, although the connecting
density is weakest for this subunit. These assignments were
based on the relative prominence of the electron density for
the carbonyl O atom and the presence of alkyl-chain density
sprouting from the carbonyl C atom in an OMIT map.
Refinement was complicated by the five half-ligands residing
in the asymmetric unit and critical density crossing the
symmetry axis. Real-space refinement in Coot was compli-
cated by the simultaneous presence of density for both
isomers, and in subunits B and D the most satisfying fit was
obtained with cis and trans isomers on a single molecule of
CPHPC. However, in this space group the symmetry requires
that the same isomer is present at each end of CPHPC, so in
subunits B and D we presume that partial occupancy by both
cis/cis and trans/trans isomers explains the density. In subunits
A and E the carbonyl of CPHPC hydrogen-bonds to a water
that is also a ligand to one of the cadmiums of the double-
metal site of the opposing subunit (see Fig. 2). For bound cis
isomers the carbonyls are directed away from this water and
form hydrogen bonds to different water molecules. In addition
to the five molecules of CPHPC and the cadmium ions, there
are few direct protein–protein interactions in the decamer.
The extended side chain of Arg77 hydrogen-bonding to
Phe144 CO provides two good hydrogen bonds on each
subunit pair and the alkyl chains of Arg77 and Lys143 are in
close contact. At this resolution it is clear that the pentamers
are displaced by rotation about their common fivefold axis by
approximately 8.
Good electron density was observed for portions of a
biantennary oligosaccharide chain covalently attached to
Asn32 of subunit D of the SAP pentamer wherever the chain
interacted with the protein (see Fig. 1d). Two terminal sialic
acids and one covalently attached N-acetylglucosamine
residue were well defined, but the density fades on moving
away from these sites. Nevertheless, a plausible model was
constructed, often building through water-molecule positions
identified earlier in refinement. The terminus of one branch of
the sugar chain hydrogen-bonds to Arg193 of the adjacent
subunit (E) of the same pentamer, while the other branch
forms a very similar interaction with Arg193 of a symmetry-
related pentamer. In the other subunits these interaction
regions are blocked by adjacent molecules in the lattice and
electron density is only visible for the first protein-bound
N-acetylglucosamine residue. While it is likely that the sugar
chain is only partially ordered in this one location owing to
packing, the fact that the same region of the protein is
involved in both an intramolecular and an intermolecular
interaction suggests that the intramolecular interaction may
contribute to the normal stability of the isolated native
pentamer.
3.2. N-Acetyl-D-proline complex
Crystals of the SAP–N-acetyl-d-proline complex grew with
a 45-fold molar excess of N-acetyl-d-proline in 60 mM Tris–
HCl pH 8.0, 10 mM CaCl2, 84 mM NaCl, 20%(v/v) glycerol,
17%(v/v) PEG 550 MME. The crystals
were monoclinic and X-ray diffraction
data were collected from a single crystal
to a resolution of 1.6 A˚ on beamline I03
at DLS (see Table 1). The molecular-
replacement solution showed one SAP
pentamer in the asymmetric unit and an
estimated solvent content of 53%. Five
d-proline ligands were observed bound
to each SAP pentamer via the double
calcium sites on each subunit. The
puckered proline ring plane is parallel
to that of Tyr74, but the penetration of
the ligand into the pocket is not suffi-
ciently deep to achieve stacking of all
atoms. Rather, the proline C and C
atoms interact with Tyr64, C and C
interact with Tyr74 and C interacts with
Leu62. The proline NH is 4.2 A˚ away
from Tyr74 OH. The peptide plane has
been built as cis; this was a marginal
decision based on the proximity of
hydrogen-bond partners (the side-chain
amide of Gln148 at 3.9 A˚ and the
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Figure 2
Conformation of CPHPC in bound trans (a, b) and cis (c) forms together with 2mFo  DFc OMIT
maps contoured at 1.2 and carved at 1.6 A˚ around ligand atoms in PyMOL (DeLano, 2002).
Orthogonal views of the same site in (a) and (b) show metal and water ligation and the kinked alkyl
chain, while views (b) and (c) show the distinct differences in the interactions of the trans and cis
isomers with water molecules. Cadmium ions and water molecules are shown in magenta and as red
spheres, respectively; CPHPC C atoms are in green.
hydroxyls of Tyr64 at 4.6 A˚ and of Tyr74 at 5.5 A˚). One
molecule of glycerol was observed binding close to Pro29 on
each subunit.
3.3. N-Acetyl-L-proline complex
Crystals were obtained from drops containing a 50-fold
molar excess of N-acetyl-l-proline with 60 mM Tris–HCl pH
8.0, 16%(v/v) PEG 550 MME, 10 mM
CaCl2, 80 mM NaCl, 0.1%(w/v) NaN3 as
the well solution. Data from a single
monoclinic crystal were collected on
station ID14-2 at the ESRF to 1.55 A˚
resolution (see Table 1). A single
pentamer was found in the asymmetric
unit by molecular replacement using
MOLREP, giving a solvent content of
56%. l-Proline molecules were identi-
fied bound to each protein subunit. The positioning of the
ligand is not unexpectedly altered compared with the
d-proline isomer. The carboxylate interaction with the calcium
ions is retained, but the pyrrolidine ring is rotated by
approximately 90 owing to the reorganization at C, and in
response the position of Tyr74 changes by 0.46 A˚. C interacts
with Tyr74, while C and C interact with Tyr64. A super-
position of the two structures is provided in Fig. 3.
3.4. CPHPC crystal structure
Crystal data for CPHPC: C16H26N2O7, Mr = 358.39, ortho-
rhombic, space group P212121, a = 10.1602 (2), b = 10.4228 (2),
c = 16.3042 (3) A˚, V= 1726.58 (6) A˚3, calc = 1.379 g cm
3, =
0.108 mm1, Z = 4, reflections collected 15 611, independent
reflections 3932 (Rint = 0.0357), final R indices [I > 2(I)] R1 =
0.0370, wR2 = 0.0823, R indices (all data) R1 = 0.0420, wR2 =
0.0857. One partially extended molecule of CPHPC and one
water molecule were present in the asymmetric unit. Both
carboxylates were protonated and hydrogen-bonded either
through a water molecule or directly to the amide-bond
carbonyl of another molecule. Although a simple rotation
about the C–carboxylate bond would enable an intramole-
cular hydrogen bond with the amide-bond carbonyl, none
were observed. The peptide bond preceding each pyrrolidine
ring was in the trans conformation. Rather than a completely
extended conformation, the central two C atoms of the linker
adopted a gauche arrangement, tilting the proline-ring planes
(see Fig. 4; CCDC deposition code 874670)1.
3.5. Calorimetry
Thermodynamic data from the binding of ligands is
summarized in Table 2 and a typical isotherm is illustrated
in Fig. 5. All calculations were based upon the SAP subunit
concentration and the stoichiometry of ligand binding was not
constrained. Nonetheless, this came very close to expectations,
with approximately half a CPHPC molecule bound per
subunit. The high affinity of the CPHPC interaction comes
close to the limit of precise measurement by this titration
procedure. The protein concentration required to give an
appropriate heat change for each injection gave a high c value
and few data points for accurate curve-fitting over the steep
decline in the enthalpy curve (Wiseman et al., 1989). A typical
Ka value (SD) was 11.3  107 (5.4  107). The error in Kd for
CPHPC is much larger than for the other ligands, but the
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Figure 4
Two molecules of the lattice of crystalline CPHPC showing intermole-
cular hydrogen bonds of the trans isomer of the d-proline head group and
the deviation of the alkyl chain from an extended form.
Table 2
Thermodynamic parameters for isothermal titration calorimetry of SAP with CPHPC, N-acetyl-d-
proline and N-acetyl-l-proline.
The error is expressed as the standard error of the mean for three experiments.
Ligand Kd (mM)
Happ
(kcal mol1)
TS
(kcal mol1)
G
(kcal mol1)
n
(stoichiometry)
N-Acetyl-l-proline 322.00  8.9 6.16  0.2 1.40  0.2 4.77  0.02 1.0
N-Acetyl-d-proline 18.60  2.2 3.44  0.6 2.69  0.5 6.12  0.4 0.9
CPHPC 0.0088  0.0026 14.87  0.8 3.83  0.7 11.04  0.2 0.4
Figure 3
Cartoon of the superposition of SAP subunits with bound molecules
of N-acetyl-d-proline (yellow C atoms) and N-acetyl-l-proline (grey C
atoms).
1 Supporting information has been deposited in the IUCr electronic archive
(Reference: MN5064).
results were reproducible in repeat experiments. Calculated
Kd values show a 2000-fold increase in the apparent affinity for
binding of half of the double-headed CPHPC compound by
the SAP subunit: 8.8 nM compared with 18.6 mM for N-acetyl-
d-proline and 322 mM for N-acetyl-l-proline. There appears to
be a substantial entropic penalty associated with the binding
of CPHPC that is broadly in accord with its larger number of
freely rotatable bonds. This implies that substantially tighter
binding might be achieved through linker rigidification, as
shown by Ho et al. (2005).
3.6. HPLC of CPHPC
Elution of CPHPC from the reversed-phase column with a
gentle acetonitrile gradient at pH 7.5 or 4.5 and 4C showed
three distinct peaks (see Fig. 6), all of which can regenerate
the original chromatogram if collected and reapplied onto the
column. These observations provide a close parallel to those
reported for the antihypertensive drug captopril (Nishikawa et
al., 2004). This Cys-l-Pro inhibitor of angiotensin-converting
enzyme oxidizes in the circulation, is excreted as a disulfide-
linked palindrome analogous to CPHPC and is subject to cis/
trans isomerization of the peptide bond preceding the proline.
Reversed-phase HPLC of oxidized captopril under similar
conditions to those reported here also generated three peaks
that were attributed to cis/cis, cis/trans and trans/trans
components eluting in that order. Based on this assignment,
the cis/trans form of CPHPC is the dominant species, while the
other two forms are present in approximately equal amounts
(25–30%) at both pH values used in crystallization. At a lower
pH of 3.0 the material redistributes towards a late-eluting
peak that probably represents the trans/trans isomer.
4. Discussion
Chemical cross-linking and gel-filtration experiments have
previously confirmed that decameric SAP is stabilized by
CPHPC in solution and is the species that forms and is cleared
in vivo following administration of the drug (Kolstoe et al.,
2009). X-ray structure analysis of SAP in complex with
CPHPC reveals the product of the cooperative high-affinity
binding of five molecules of the bivalent drug by two SAP
pentamers, cross-linking their B faces. In this interaction the
apparent affinity of the head group rises by three orders of
magnitude compared with isolated d-proline during the
calorimetric titration of the palindromic compound. The two
pentamers of SAP in the complex are out of register about
their common fivefold axis by less than 10, enabling the
formation of ten good hydrogen bonds. Other investigations of
ligand-cross-linked C-reactive protein (Pepys et al., 2006) and
SAP (Ho et al., 2005) indicate that this rotation can vary
considerably with linkers of different lengths. Optimal linker
lengths are likely to be those that balance flexibity with
enabling protein–protein interactions. The proximity of the
pentamers required for such interactions is likely to be regu-
lated by the shape of the opposing protein surfaces and the
research papers
2238 Kolstoe et al.  Serum amyloid P component Acta Cryst. (2014). D70, 2232–2240
Figure 6
Elution profiles (UV absorption at 220 nm) of CPHPC from a reversed-
phase column with acetonitrile gradients (acetonitrile, green line;
aqueous, red line) at 4C and pH values close to those employed in the
crystallization of the protein complexes, showing three species corre-
sponding to cis/cis (25%), cis/trans (45%) and trans/trans (30%) isomers
at pH 4.5.
Figure 5
Isothermal titration calorimetry traces for the binding of CPHPC by SAP
at 25C and the best-fit curve (red) used to estimate Kd.
complementarity of charge and hydrogen-bonding capacity.
The structure presented may be one of several possible low-
energy rotamers.
While improved resolution of the structural analysis has
been enabled by co-crystallization with cadmium ions, this has
not entirely clarified the issue of any isomer preference for the
CPHPC bound by SAP. In the conditions used here there
are clearly preferred isomers for certain subunits and specific
bonding interactions that might explain their presence. Isomer
distribution does not appear to be a passive reflection of the
solution composition during crystallization. HPLC shows that
several isomeric forms of CPHPC can exist in solution and
suggests that the mixed cis/trans isomer is the most abundant.
However, this form is not consistent with the crystal symmetry.
Crystal-packing effects and disorder might be invoked to
explain the variability, but we are not able to provide a robust
structural explanation for their influence on isomer preference
at different positions. Subunits A and E show a clear prefer-
ence for trans isomers and bonding interactions that stabilize
them, but the partners in these interactions are still present
in other subunits where cis isomers are bound. Although the
proline ring of SAP is located in a pocket, there are no close
interactions with protein side chains that might favour
deconjugation of the peptide bond or pyramidalization of the
proline N atom to promote isomerization within the binding
site.
In solution, CPHPC shows a mixture of isomeric forms that
can readily interconvert depending upon the conditions, and
this behaviour is very similar to that of captopril and its
oxidation product. NMR titrations of captopril showed a
marked pH dependence of the isomer distribution, favouring
the trans isomer at low pH (Rabenstein & Isab, 1982). This
stability was attributed in part to the likely formation of
an intramolecular hydrogen bond between the protonated
carboxylate and the carbonyl O atom preceding the proline. It
is of note that when the CPHPC carboxylate is coordinating
the protein-bound cadmium ions and the pH dictates that it
is ionized, there is no capacity for hydrogen bonding to the
amide-bond carbonyl, removing this favourable interaction
for stabilizing the trans isomer. However, this mode of
hydrogen bonding is also not present in the all-trans crystalline
CPHPC at low pH. Rather, in both cases a water molecule
is the hydrogen-bond partner. Raising the temperature of
the HPLC runs for captopril disulfide changes the isomer
composition towards later-eluting peaks corresponding to the
trans/trans isomer. At 37C nearly all of the material elutes
at this position as the energy barrier to isomerization is
overcome and the most stable trans isomer is accessible. As
CPHPC behaves in a very similar fashion, one might expect
the trans/trans state to predominate in vivo at this temperature
following drug administration.
In solution, the cross-linked SAP decamer may well be a
flexible structure owing to the capacity for bond rotations
in the ligand linker and sparse protein–protein interactions
between SAP pentamers enabling their relative rotation.
Binding of multiple cadmium ions at the pentamer interface
probably damps this motion and provides a species that
crystallizes rather well (Trakhanov et al., 1998). From the
structure of the complex, we see that cadmium ions outside
the primary sites do not make interactions with the ligand and
any influence that they may exert on the ligand conformation
must be transmitted through the protein.
One can envisage a complex range of species emerging
during the assembly of the decameric SAP–CPHPC complex.
The most probable initial species are SAP pentamers with one
or more CPHPC molecules attached through a single head
group but with a distribution of cis and trans isomers of both
head groups reflecting the equilibrium in solution. These
species might preferentially interact with other constituents
containing a complementary loading to form partially or fully
loaded decamers. Less common collision complexes might
result in pairs of SAP pentamers linked by a single or a small
number of CPHPC molecules. In these cases the reduced
degrees of freedom substantially raise the probability of
binding further CPHPC molecules through both head groups
in an escalating zipper-like manner. With a large excess of
CPHPC one might expect all sites on an individual SAP
pentamer to be filled with CPHPC through a single head
group and for decamer formation to be inhibited. Indeed, we
have previously reported that isolated human SAP runs as
a single pentamer on size-exclusion chromatography in the
presence of calcium and a 128-fold molar excess of CPHPC.
Ho and coworkers described a crystal structure for such a non-
cross-linked ligand–SAP complex (Ho et al., 2005). They also
described a structure for decameric SAP in which only three
bivalent ligands are bound. Even if this crystal form was in
part determined by crystal-packing effects, it does provide
some evidence for stable, partially cross-linked SAP decamers
implied by the discussion of assembly above. Similarly, in vivo
infusion of CPHPC in humans initiates rapid depletion of
plasma SAP when the molar ratio of CPHPC to SAP is just
1:1, indicating the formation of complexes composed of two
SAP molecules cross-linked by just two CPHPC molecules.
The diastereoisomer of proline in CPHPC that was selected
by high-throughput screening is not commonly found in
biological systems. Nevertheless, we find that l-proline can be
accommodated in the binding site of SAP, albeit with a tenfold
reduction in affinity compared with the d isomer. Cooperative
multipoint attachment of SAP to an l-proline-containing
ligand could only promote this affinity with the involvement
of an adjacent carboxylate. C-terminal proline residues that
would fulfil this requirement are not common in known
amyloid fibre proteins or their cleavage products. It seems
most likely, therefore, that the high-throughput screen that
identified the d-proline head group of CPHPC fortuitously
located an atomic ensemble that mimics the amyloid motif
recognized by SAP.
We have cited above various aspects of the SAP-bound
form of CPHPC that might be varied to achieve tighter
binding; variation of the linker length enables access to
different pentamer rotations and locked cis-proline isomers
are worthy of consideration since cis/cis isomers are bound in
spite of their limited abundance. In a related way, Ho et al.
(2005) reported a distinct chair form of the dioxane ring of the
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SAP-bound pyruvate acetal of glycerol that is not observed by
NMR of the ligand in solution.
The efficacy of CPHPC in vivo in clearing circulating SAP is
dramatic by virtue of the efficiency of hepatic recognition of
the cross-linked SAP decamer. This ability to reduce plasma
SAP concentrations with CPHPC is pivotal in the rapidly
advancing use of CPHPC for the treatment of systemic
amyloidosis (Gillmore et al., 2010; Bodin et al., 2010; http://
www.clinicaltrials.gov/ct2/show/NCT01777243?term=amyloid+
gsk&rank=2) and also offers exciting potential in Alzheimer’s
disease (Kolstoe et al., 2009). Furthermore, SAP binds avidly
to DNA (Pepys & Butler, 1987) and may be responsible for
the failure of DNA vaccination in humans compared with
other species (Wang et al., 2011). A clinical trial of SAP
depletion in this context is currently in progress (M. B. Pepys,
personal communication).
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